The attitudes of family physicians toward a child with delayed growth and development

Servet Aker1, Mustafa Kürşat Şahin2, Ömer Kınalı3

  • 11Canik Community Health Center,Public Health Directorate,Samsun,Turkey.

Insights

Family physicians often used judgmental language when interviewing mothers of children with developmental delays. Further training is recommended to improve communication and patient relations in primary care settings.

Area of Science:

  • Pediatrics
  • Family Medicine
  • Developmental Pediatrics

Background:

  • Primary healthcare professionals are crucial for monitoring child health through growth and development assessments.
  • Early detection of delayed growth and development can significantly improve outcomes.
  • Family physicians play a pivotal role in identifying and managing developmental concerns.

Purpose of the Study:

  • To evaluate the attitudes and communication styles of family physicians when interacting with families of children experiencing delayed growth and development.
  • To identify potential areas for improvement in how family physicians approach sensitive developmental issues.

Main Methods:

  • A descriptive study involving 325 family physicians in Samsun, Turkey.
  • Utilized role-playing scenarios depicting a child with delayed growth and development, followed by participant interviews.
  • Administered a questionnaire with open-ended questions to gather further insights.

Main Results:

  • Family physicians frequently employed accusatory and judgmental language during interviews with mothers.
  • Common questions included inquiries about maternal competence, such as 'Do you think you are a good mother?'.
  • Physicians expressed a strong belief in educational interventions for resolving developmental delays.

Conclusions:

  • The communication and relationship-building approaches of family physicians with patients and their relatives were found to be inappropriate.
  • There is a clear need for continuous in-service training for family physicians on effectively managing cases of delayed growth and development.

Related Concept Videos

Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
22.6K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
411
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
293
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
340
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.2K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
388